Researchers have used stem cells as a “cargo ship” to carry genetic information to produce an enzyme that mimics the activity of alpha-galactosidase A, the enzyme missing in Fabry disease, according to a proof-of-concept study in mice. When injected into a mouse model of Fabry disease, this enzyme, called…
Two upcoming gatherings are reminders about the importance — and availability — of Fabry disease information for those like me who live with the condition. First up is the 13th annual Fabry Family Education Conference, set for Sept. 20-22 in Greensboro, North Carolina. Close on its heels, Sept.
My first column for Fabry Disease News introduced readers to my family’s Fabry story. In it, I described the unexpected “crooked lines” of a summer trip that led to my twin teenage sons — Anthony and Michael — being diagnosed. As we evaded one storm — with…
Enzyme replacement therapy (ERT) can help to increase the bone density of male patients with Fabry disease, who tend to have lower bone mineral density, a study has found. Female patients, by contrast, were found generally not to have low bone density, and ERT did not substantially change…
A rare pair of mutations were identified as the likely cause of Fabry disease for a young man with cardiac involvement in Japan who was successfully treated with Galafold (migalastat). While the clinical significance of the two mutations has not been well established, researchers believe their combined effects…
An imaging technology called 3D echocardiography, which allows clinicians to visualize the heart in three dimensions and measure the strain on heart tissue when the heart beats, may be useful for assessing heart damage among people with Fabry disease. That’s according to the study, “Three-dimensional echocardiographic…
I’ve been receiving biweekly infusions of enzyme replacement therapy for Fabry disease for over 20 years, and I had a heart transplant in September 2020. With these two amazing gifts, almost all my Fabry symptoms have improved significantly. Those gains are multifarious and have bettered my quality…
People with Fabry disease commonly have abnormalities in the brain’s blood vessels, such as unusually thick vessel walls or differences in how the vessels respond to changes in oxygen levels in the blood. That’s according to the study, “Cerebrovascular Phenotype in Fabry Disease Patients Assessed by Ultrasound,” which…
Our family’s Fabry disease story started in the summer of 2019. I had driven a carload of teens from Dallas to my Cajun homeland for a youth camp, which was unexpectedly cut short because Hurricane Barry was poised to bear down. Frenzied, friendly camp staff helped us pack…
AceLink Therapeutics’ Phase 2 trial testing AL1211 as a treatment for Fabry disease has been cleared to launch by the U.S. Food and Drug Administration (FDA). The trial will evaluate AL1211’s safety and pharmacological properties in men diagnosed with classic Fabry disease who are willing to switch…
Get regular updates to your inbox.